Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsScientists discuss the progress made in induced pluripotent stem cells (iPSC)-derived T cells and provides a roadmap for the development of CAR iPSC-derived T cells and off-the-shelf T-iPSCs.
[Pharmaceutical Research]
6445212 XD3SPZS5 items 1 apa 0 default asc 1 163403 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-e1ef35d62f5f96dd31db10904bca1980%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22XD3SPZS5%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sadeqi%20Nezhad%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESadeqi%20Nezhad%2C%20M.%2C%20Abdollahpour-Alitappeh%2C%20M.%2C%20Rezaei%2C%20B.%2C%20Yazdanifar%2C%20M.%2C%20%26amp%3B%20Seifalian%2C%20A.%20M.%20%282021%29.%20Induced%20Pluripotent%20Stem%20Cells%20%28iPSCs%29%20Provide%20a%20Potentially%20Unlimited%20T%20Cell%20Source%20for%20CAR-T%20Cell%20Development%20and%20Off-the-Shelf%20Products.%20%3Ci%3EPharmaceutical%20Research%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11095-021-03067-z%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11095-021-03067-z%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DXD3SPZS5%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Induced%20Pluripotent%20Stem%20Cells%20%28iPSCs%29%20Provide%20a%20Potentially%20Unlimited%20T%20Cell%20Source%20for%20CAR-T%20Cell%20Development%20and%20Off-the-Shelf%20Products%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Sadeqi%20Nezhad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meghdad%22%2C%22lastName%22%3A%22Abdollahpour-Alitappeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Behzad%22%2C%22lastName%22%3A%22Rezaei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahboubeh%22%2C%22lastName%22%3A%22Yazdanifar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20Marcus%22%2C%22lastName%22%3A%22Seifalian%22%7D%5D%2C%22abstractNote%22%3A%22Chimeric%20antigen%20receptor%20T%20%28CAR-T%29%20cell%20therapy%20has%20been%20increasingly%20conducted%20for%20cancer%20patients%20in%20clinical%20settings.%20Progress%20in%20this%20therapeutic%20approach%20is%20hampered%20by%20the%20lack%20of%20a%20solid%20manufacturing%20process%2C%20T%20lymphocytes%2C%20and%20tumor-specific%20antigens.%20T%20cell%20source%20used%20in%20CAR-T%20cell%20therapy%20is%20derived%20predominantly%20from%20the%20patient%5Cu2019s%20own%20T%20lymphocytes%2C%20which%20makes%20this%20approach%20impracticable%20to%20patients%20with%20progressive%20diseases%20and%20T%20leukemia.%20The%20generation%20of%20autologous%20CAR-T%20cells%20is%20time-consuming%20due%20to%20the%20lack%20of%20readily%20available%20T%20lymphocytes%20and%20is%20not%20applicable%20for%20third-party%20patients.%20Pluripotent%20stem%20cells%2C%20such%20as%20human%20induced%20pluripotent%20stem%20cells%20%28hiPSCs%29%2C%20can%20provide%20an%20unlimited%20T%20cell%20source%20for%20CAR-T%20cell%20development%20with%20the%20potential%20of%20generating%20off-the-shelf%20T%20cell%20products.%20T-iPSCs%20%28iPSC-derived%20T%20cells%29%20are%20phenotypically%20defined%2C%20expandable%2C%20and%20as%20functional%20as%20physiological%20T%20cells.%20The%20combination%20of%20iPSC%20and%20CAR%20technologies%20provides%20an%20exciting%20opportunity%20to%20oncology%20and%20greatly%20facilitates%20cell-based%20therapy%20for%20cancer%20patients.%20However%2C%20T-iPSCs%2C%20in%20combination%20with%20CARs%2C%20are%20at%20the%20early%20stage%20of%20development%20and%20need%20further%20pre-clinical%20and%20clinical%20studies.%20This%20review%20will%20critically%20discuss%20the%20progress%20made%20in%20iPSC-derived%20T%20cells%20and%20provides%20a%20roadmap%20for%20the%20development%20of%20CAR%20iPSC-derived%20T%20cells%20and%20off-the-shelf%20T-iPSCs.%22%2C%22date%22%3A%222021-06-10%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1007%5C%2Fs11095-021-03067-z%22%2C%22ISSN%22%3A%221573-904X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11095-021-03067-z%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-06-11T23%3A29%3A39Z%22%7D%7D%5D%7D
Sadeqi Nezhad, M., Abdollahpour-Alitappeh, M., Rezaei, B., Yazdanifar, M., & Seifalian, A. M. (2021). Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf Products. Pharmaceutical Research. https://doi.org/10.1007/s11095-021-03067-z Cite
